ATNF180 Life Sciences Corp.

Nasdaq 180lifesciences.com


$ 2.01 $ 0.16 (8.74 %)    

Tuesday, 17-Sep-2024 15:57:31 EDT
QQQ $ 473.83 $ 0.25 (0.05 %)
DIA $ 417.12 $ -0.12 (-0.03 %)
SPY $ 563.14 $ 0.23 (0.04 %)
TLT $ 100.82 $ -0.49 (-0.48 %)
GLD $ 237.35 $ -1.32 (-0.55 %)
$ 1.99
$ 1.99 x 100
-- x --
-- - --
$ 1.31 - $ 15.49
54,589
na
1.83M
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 180-life-sciences-announces-the-appointment-of-omar-jimenez-as-chief-financial-officer-effective-september-30-2024

180 Life Sciences Corp. ("180" or the "Company") is pleased to announce the appointment of Omar Jimenez as its ...

 180-life-sciences-granted-european-patent-ep3265107-for-treating-dupuytrens-disease-using-tnf-receptor-2-antagonist

https://register.epo.org/application?number=EP16759326

 180-life-sciences-reports-positive-topline-results-of-a-clinical-pharmacology-study-testing-a-new-solid-formulation-of-cbd-with-enhanced-oral-uptake-twelve-volunteers-received-all-three-formulations-in-a-crossover-randomized-trial

180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced topline results f...

 180-life-sciences-granted-an-additional-extension-by-nasdaq-hearing-panel-to-regain-compliance-with-continued-listing-requirements

180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that it received ...

 180-life-sciences-granted-extension-by-nasdaq-hearing-panel-to-regain-compliance-with-continued-listing-requirements

- SEC Filing

 180-life-sciences-says-james-n-woody-resigned-as-ceo-and-as-board-member-on-may-7-2024

On May 7, 2024, Dr. Jonathan Rothbard resigned as Chief Scientific Officer of the Company

 180-life-sciences-regains-full-compliance-with-nasdaq-minimum-bid-price-requirement

180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced that the Company ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION